ILLUMINA, INC.
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
- Ticker / security symbols
- ILMN [1]
- Listing exchanges
- Nasdaq [1]
- SEC industry
- Laboratory Analytical Instruments [1]
- Business sectors
- biotechnology [2]
- Company / filing name
- ILLUMINA, INC. [1]
- Headquarters location
- San Diego [2]
- Business address
- 5200 ILLUMINA WAY, SAN DIEGO, CA, 92122 [1]
- Founded
- 1998 [2]
- Legal form
- simplified joint-stock company [2]
- Incorporation jurisdiction
- Delaware, United States [1]
- Official website
- www.illumina.com ↗ [2]
- Fiscal year end
- January 3 (SEC record) [1]
- ISIN (reported securities)
- US4523271090 [2]
- CIK
- 0001110803 [1]
- SIC code
- 3826 [1]
- Country in background record
- United States [2]
Company positioning and business
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries. [3]
Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. [3]
Background text: Wikipedia contributors, Illumina, Inc.. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.
Financial year, securities and disclosures
The SEC submissions record gives ILLUMINA, INC. a fiscal year end of 0103 (MMDD). Individual filings below identify their own reporting period; the filing date is the publication event, not the financial year end. [1]
Listed securities: ILMN (Nasdaq). Multiple symbols may represent different share classes or securities of the same registrant. [4]
History and key events
Financial results and regulatory disclosures
Annual, quarterly and current reports from the collected SEC record. Insider Forms 4 and 144 are excluded. This is a selected list, not a live filing feed.
Source-verified relationships
Companies in the same industry
Comparison candidates share the SEC SIC classification 3826. This does not imply ownership, partnership or trading relationships.
Related entities and concepts
Frequently asked questions
When was ILLUMINA, INC. founded?
Founded: 1998. The linked source provides the background record. [2]
Where is the headquarters of ILLUMINA, INC.?
Headquarters location: San Diego. The linked source provides the background record. [2]
Which business sectors are recorded for ILLUMINA, INC.?
Business sectors: biotechnology. The linked source provides the background record. [2]
ILLUMINA, INC. relationship map
Select a node to inspect its relationship and source.
2 verified direct relationships. Industry peers are not relationship edges.
Sources and review dates
- SEC — ILLUMINA, INC. filing identity and securities ↗
- Wikidata — company background record (CC0) ↗
- Wikipedia contributors — Illumina, Inc. (CC BY-SA 4.0) ↗
- SEC securities directory ↗
- Company chronology / filing ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.